Proteomics and its role in drug discovery and development

被引：0

|

作者：

Nishimura, T ^{[1
]}

机构：

[1] Tokyo Med Univ, Clin Proteom Ctr, Shinjuku Ku, Tokyo 1630203, Japan

来源：

SEIKAGAKU | 2004年 / 76卷 / 10期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

收藏

页码：1344 / 1352

页数：9

相关论文

共 50 条

[31] Proteomics approaches in drug discovery
Figeys, D
ANALYTICAL CHEMISTRY, 2002, 74 (15) : 413A - 419A
[32] Proteomics and drug discovery in cancer
Dias, Matheus H.
Kitano, Eduardo S.
Zelanis, Andre
Iwai, Leo K.
DRUG DISCOVERY TODAY, 2016, 21 (02) : 264 - 277
[33] Drug Discovery and Development: the Role of NMR
Everett, Jeremy R.
EMAGRES, 2015, 4 (01): : 137 - 149
[34] Role of pharmacogenomics in drug discovery and development
Surendiran, A.
Pradhan, S. C.
Adithan, C.
INDIAN JOURNAL OF PHARMACOLOGY, 2008, 40 (04) : 137 - 143
[35] The role of academia in drug discovery and development
Yamada, Yasuhide
Kim, Tae Won
CANCER SCIENCE, 2018, 109 : 42 - 42
[36] The Role of Radiopharmaceuticals in Drug Discovery and Development
Kairemo, Kalevi
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (09) : 926 - 927
[37] THE ROLE OF REDUCTASES IN DRUG DISCOVERY AND DEVELOPMENT
Di, Li
DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : S62 - S62
[38] Role of toxicology in drug discovery and development
Goldstein, RS
IDEA TO PRODUCT: THE PROCESS, 1996, : 47 - 48
[39] The role of emerging genomics and proteomics technologies in cancer drug target discovery
Onyango, P
CURRENT CANCER DRUG TARGETS, 2004, 4 (02) : 111 - 124
[40] Role of Mathematical Chemodescriptors and Proteomics-Based Biodescriptors in Drug Discovery
Basak, Subhash C.
DRUG DEVELOPMENT RESEARCH, 2011, 72 (02) : 225 - 233

← 1 2 3 4 5 →